Heart Failure News and Research

RSS

Heart failure (HF) is a condition in which a problem with the structure or function of the heart impairs its ability to supply sufficient blood flow to meet the body's needs. It should not be confused with cardiac arrest or myocardial infarction.

Cardiovascular risk factors – not preexisting heart disease – are the main contributors to COVID-19 death

A national study suggests that risk factors for cardiovascular disease, such as age, smoking and diabetes – not preexisting heart disease – are the main contributors to death and poor outcomes for critically ill COVID-19 patients.

12 Oct 2022

Sustained blood pressure control necessary to reduce the burden of fatal cardiovascular events

In 2015, published findings from the landmark Systolic Blood Pressure Intervention Trial (SPRINT) showed that intensive blood pressure management reduced cardiovascular disease and lowered the risk of death. In 2019, results of the SPRINT MIND trial showed that lowering blood pressure also reduced the risk of mild cognitive impairment in older adults.

12 Oct 2022

Common diabetes medication identified as a possible treatment for atrial fibrillation

Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible treatment for atrial fibrillation.

11 Oct 2022

Study offers a systems biology strategy to facilitate the search for effective COVID-19 drugs

A Cleveland Clinic-led research team used artificial intelligence to map out hundreds of ways that the virus that causes COVID-19 interacts with infected cells.

10 Oct 2022

Discovery could play an important role in future medicines to heal damaged hearts

Scientists at the UNC School of Medicine have made a significant advance in the promising field of cellular reprogramming and organ regeneration, and the discovery could play a major role in future medicines to heal damaged hearts.

6 Oct 2022

Wake Forest receives $30 million award to support research on rehab program for heart failure patients

The National Institute of Aging, part of the National Institutes of Health, recently awarded Wake Forest University School of Medicine a five-year grant expected to total $30 million to support research to test a novel rehabilitation program designed for older patients hospitalized for acute heart failure.

6 Oct 2022

Wear and tear from lifelong stress can lead to increased risk of dying from cancer

The wear and tear on the body from chronic and lifelong stress can also lead to an increased risk of dying from cancer, Medical College of Georgia researchers report.

6 Oct 2022

Daxor's BVA-100 diagnostic blood test reduces hospital length of stay for heart failure patients

Daxor Corporation, the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company's BVA-100 diagnostic blood test in reducing hospital length of stay (LOS) for heart failure (HF) patients.

3 Oct 2022

New data validates the benefits of Daxor's BVA-100 blood test for heart failure patients

Daxor Corporation, the global leader in blood volume measurement technology, today announces new data validating the benefits of the Company's BVA-100 blood test for heart failure patients. Data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2022 – which brought together the world's leading experts in heart failure from September 30th thru October 3rd, 2022, in Washington, DC.

3 Oct 2022

Omega-3 fatty acids can stimulate active healing of inflammation in cases of severe COVID-19

Intravenous treatment with omega-3 fatty acids in elderly hospitalized patients in intensive care due to COVID-19 seems to have positive effects on the ability of the immune system to cope with the virus, according to a study from Karolinska Institutet in Sweden.

29 Sep 2022

Cardiac inflammation after mild COVID-19 in previously healthy people

A new study published in the journal Nature Medicine aimed to analyze the association of lingering cardiac symptoms with mild COVID-19.

27 Sep 2022

Leducq Foundation awards $15 million to advance the understanding of atherosclerosis

The Leducq Foundation has awarded $15 million to researchers at UVA Health and their collaborators to advance our understanding of atherosclerosis, or hardening of the arteries, and find better ways to treat it. Diseases linked to atherosclerosis are the leading cause of death in the United States.

27 Sep 2022

The potential of NMR-based blood profiling as a single-domain assay to simultaneously predict multidisease onset

Researchers explored the potential of a nuclear magnetic resonance spectroscopy-based metabolomic platform to estimate the risks for the onset of several medical conditions.

27 Sep 2022

Coffee drinking linked with longer lifespan and lower risk of cardiovascular disease

Drinking two to three cups of coffee a day is linked with a longer lifespan and lower risk of cardiovascular disease compared with avoiding coffee, according to research published today in the European Journal of Preventive Cardiology, a journal of the ESC.

26 Sep 2022

Heart Failure News and Research

Further Reading

Cardiovascular risk factors – not preexisting heart disease – are the main contributors to COVID-19 death

Sustained blood pressure control necessary to reduce the burden of fatal cardiovascular events

Common diabetes medication identified as a possible treatment for atrial fibrillation

Study offers a systems biology strategy to facilitate the search for effective COVID-19 drugs

Discovery could play an important role in future medicines to heal damaged hearts

Wake Forest receives $30 million award to support research on rehab program for heart failure patients

Wear and tear from lifelong stress can lead to increased risk of dying from cancer

Daxor's BVA-100 diagnostic blood test reduces hospital length of stay for heart failure patients

New data validates the benefits of Daxor's BVA-100 blood test for heart failure patients

Omega-3 fatty acids can stimulate active healing of inflammation in cases of severe COVID-19

Cardiac inflammation after mild COVID-19 in previously healthy people

Leducq Foundation awards $15 million to advance the understanding of atherosclerosis

The potential of NMR-based blood profiling as a single-domain assay to simultaneously predict multidisease onset

Coffee drinking linked with longer lifespan and lower risk of cardiovascular disease

Prevention of cardiovascular disease is important in cancer patients

Study shows the importance of night-time blood pressure assessment for diagnosing hypertension

Collaborative, home-based palliative care may improve end-of-life outcomes for people with chronic heart failure

Only 48% of older adults regularly check their blood pressure at home, study finds

Cutting-edge technology uses MRI to diagnose patients with heart failure in record time

Cardiovascular disease risk factors are largely the same for women and men, study shows

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News